Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-06 Sale | 2026-07-07 7:50 pm | NovaBridge Biosciences | NBP | Xu Cong Claire SVP, Clinical Development | 4,485 | $0.89 | $3,992 | 298,101 (Direct) | View |
| 2026-06-18 Sale | 2026-06-22 5:23 pm | NovaBridge Biosciences | NBP | Dennis Phillip Andrew Chief Medical Officer | 8,494 | $0.66 | $5,606 | 240,363 (Direct) | View |
| 2026-06-01 Sale | 2026-06-02 6:46 pm | NovaBridge Biosciences | NBP | Xu Cong Claire SVP, Clinical Development | 3,494 | $3.94 | $13,766 | 322,791 (Direct) | View |
| 2026-05-14 Sale | 2026-05-18 4:05 pm | NovaBridge Biosciences | NBP | Cao Sean Wuxiong See Remarks | 21,399 | $1.99 | $42,584 | 35,073 (Direct) | View |
| 2026-04-24 Purchase | 2026-04-28 4:05 pm | NovaBridge Biosciences | NBP | Hagler Mark Arnold See Remarks | 230,000 | $2.51 | $577,300 | 230,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-22 Exercise | 2026-08-25 4:15 pm | N/A N/A | NovaBridge Biosciences | NBP | Lenz Robert A. Director | 24,704 | $0 | 32,192 (Direct) | View |
| 2026-07-08 Option Award | 2026-07-10 5:00 pm | N/A 2036-07-08 | NovaBridge Biosciences | NBP | Hagler Mark Arnold Chief Commercial Officer | 949,050 | $0 | 949,050 (Direct) | View |
| 2026-07-08 Option Award | 2026-07-10 5:00 pm | N/A 2036-07-08 | NovaBridge Biosciences | NBP | Lin Liwei Lorraine General Counsel | 254,780 | $0 | 254,780 (Direct) | View |
| 2026-07-06 Option Award | 2026-07-08 4:26 pm | N/A 2036-07-06 | NovaBridge Biosciences | NBP | Gupta Srishti Chief Executive Officer | 3,000,000 | $0 | 3,000,000 (Direct) | View |
| 2026-07-04 Exercise | 2026-07-07 7:50 pm | N/A N/A | NovaBridge Biosciences | NBP | Xu Cong Claire SVP, Clinical Development | 17,837 | $0 | 298,101 (Direct) | View |
| 2026-06-29 Option Award | 2026-06-30 4:15 pm | N/A 2036-06-29 | NovaBridge Biosciences | NBP | Fu Wei Director | 3,910,680 | $0 | 3,910,680 (Direct) | View |
| 2026-06-22 Option Award | 2026-06-24 7:22 pm | N/A N/A | NovaBridge Biosciences | NBP | Cao Sean Wuxiong Chief Bus. Development Officer | 362,570 | $0 | 362,570 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-22 5:23 pm | N/A N/A | NovaBridge Biosciences | NBP | Dennis Phillip Andrew Chief Medical Officer | 33,997 | $0 | 240,363 (Direct) | View |
| 2026-05-30 Exercise | 2026-06-02 6:46 pm | N/A N/A | NovaBridge Biosciences | NBP | Xu Cong Claire SVP, Clinical Development | 13,461 | $0 | 322,791 (Direct) | View |
Ownership(A) | 2026-04-10 4:18 pm | N/A N/A | NovaBridge Biosciences | NBP | Xu Cong Claire See Remarks | 0 | $0 | 284,266 (Direct) | View |
Ownership | 2026-04-01 06:11 am | N/A 2034-10-01 | NovaBridge Biosciences | NBP | Yang Conor Chia-hung Director | 0 | $0 | 148,623 (Direct) | View |
Ownership | 2026-03-19 06:18 am | N/A N/A | NovaBridge Biosciences | NBP | Dennis Phillip Andrew Chief Medical Officer | 0 | $0 | 916,274 (Direct) | View |
Ownership | 2026-03-18 9:44 pm | N/A N/A | NovaBridge Biosciences | NBP | Fu Xi-Yong See Remarks | 0 | $0 | 2,549,823 (Direct) | View |
Ownership | 2026-03-18 9:40 pm | N/A N/A | NovaBridge Biosciences | NBP | Zhang Xiaofan Neo Chief Investment Officer | 0 | $0 | 874,000 (Direct) | View |
Ownership | 2026-03-18 9:40 pm | N/A 2035-10-16 | NovaBridge Biosciences | NBP | Lei Ming Kyler Chief Financial Officer | 0 | $0 | 996,775 (Direct) | View |
Ownership | 2026-03-18 9:39 pm | N/A N/A | NovaBridge Biosciences | NBP | Wu Joanna Xuqiong See Remarks | 0 | $0 | 76,794 (Direct) | View |
Ownership | 2026-03-18 9:37 pm | N/A N/A | NovaBridge Biosciences | NBP | Fu Wei Director | 0 | $0 | 37,042,594 (Indirect) | View |
Ownership | 2026-03-18 9:37 pm | N/A N/A | NovaBridge Biosciences | NBP | Cao Sean Wuxiong See Remarks | 0 | $0 | 893,704 (Direct) | View |
Ownership | 2026-03-18 9:36 pm | N/A 2036-02-17 | NovaBridge Biosciences | NBP | Cunningham Emmett Director | 0 | $0 | 120,000 (Direct) | View |
Ownership | 2026-03-18 9:35 pm | N/A N/A | NovaBridge Biosciences | NBP | Xu Cong Claire See remarks | 0 | $0 | 653,667 (Direct) | View |
Ownership | 2026-03-18 9:30 pm | N/A 2035-10-15 | NovaBridge Biosciences | NBP | Woo Ian Ying Director | 0 | $0 | 33,160 (Direct) | View |
Ownership | 2026-03-18 9:25 pm | N/A 2035-08-22 | NovaBridge Biosciences | NBP | Lenz Robert A. Director | 0 | $0 | 41,590 (Direct) | View |
Ownership | 2026-03-18 9:24 pm | N/A 2034-10-01 | NovaBridge Biosciences | NBP | Au Chun Kwok Alan Director | 0 | $0 | 148,623 (Direct) | View |